Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hypoxia × Biopsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 34 Prostatic Neoplasms 16 Melanoma 14 Lung Neoplasms 13 Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Lymphoma 8 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 7 Uterine Cervical Neoplasms 6 Leukemia 6 Breast Neoplasms, Male 6 Urinary Bladder Neoplasms 5 Precancerous Conditions 5 Lymphoma, Follicular 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Colonic Neoplasms 5 Adenocarcinoma Of Esophagus 5 Pancreatic Neoplasms 4 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Congenital Abnormalities 4 Barrett Esophagus 4 Vulvar Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 3

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3 pimonidazole 2 TH 302 2 gadobutrol 1 fluoromisonidazole 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Radiotherapy 1 Propofol 1 Pancreaticoduodenectomy 1 Oxygen 1 Ketamine 1 Gemcitabine 1 Ferrosoferric Oxide 1 Dexmedetomidine 1 Blood Specimen Collection 1 Biopsy 1 Bacterial Load 1 Atovaquone 1 3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157246 2017-03-13

RHYTHM-I

University of Oxford

Phase NA Completed

Gastrointestinal

Hypoxia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡